Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001558370-22-000991
Filing Date
2022-02-10
Accepted
2022-02-10 12:40:41
Documents
1
Group Members
BRIDGESUPPORT@TOPPANMERRILL.COM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tmb-20220210xsc13ga.htm SC 13G/A 39608
  Complete submission text file 0001558370-22-000991.txt   41198
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filed by) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Subject) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90859 | Film No.: 22612597
SIC: 2836 Biological Products, (No Diagnostic Substances)